COVID-19 Evidence Alerts
from McMaster PLUSTM

Current best evidence for clinical care (more info)

COVID-19 Evidence Alerts needs your support. If our service is of value to you, please consider giving to keep it going. Learn more Give now

Treatment Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, et al. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2021 May;174(5):673-679. doi: 10.7326/M20-8101. Epub 2021 Feb 9.
Ratings
Discipline / Specialty Area Score
Intensivist/Critical Care
Respirology/Pulmonology
Hospital Doctor/Hospitalists
Internal Medicine
Infectious Disease
Coming soon...
Comments from MORE raters

Internal Medicine rater

It is good to have more data on this. The Solidarity trial, which was the largest trial, didn't show any difference in mortality. For hospitalized patients requiring supplemental oxygen, dexamethasone +/- remdesivir is the way to go.